Please login to the form below

Not currently logged in
Email:
Password:

Rixubis

This page shows the latest Rixubis news and features for those working in and with pharma, biotech and healthcare.

Novo Nordisk files improved haemophilia B therapy in EU

Novo Nordisk files improved haemophilia B therapy in EU

Behring and Baxalta, which launched BeneFix rival Rixubis in 2013.

Latest news

More from news
Approximately 1 fully matching, plus 8 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Grace Communications

Grace Communications is a creative agency specialising in healthcare communication and understanding people's personality types....

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics